Skip to content
DataLookout
Menu

COMPAWANCT05560204

Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 31, 2026 to Dec 31, 2027 Show 5 more changesShow less
    • Eligibility criteria revised
    • Study completion pushed from Dec 31, 2027 to Apr 28, 2028
    • Study sites: 1 to 3
    • Secondary endpoints: details revised at 10 of 10 entries
    • Study description expanded, about 3 words
  2. Notable Eligibility criteria expanded, about 9 words Show 4 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    • Secondary endpoints: details revised at 1 of 10 entries
    • Publications: details revised at 13 of 13 entries
  3. Notable Phase: Not specified to Not applicablev3 Show 6 more changesShow less
    • Primary completion date: Oct 31, 2026 to Dec 31, 2026
    • Study completion date: Oct 30, 2027 to Dec 31, 2027
    • Start date changed from estimate of Nov 1, 2022 to Jan 1, 2023
    • Interventions: Combined Pulsed-field Ablation (PFA) (Procedure) to Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) (Device)
    • Secondary endpoints: details revised at 5 of 10 entries
    • Study arms: 0 to 2
  4. Notable Start date: Jun 1, 2022 to Nov 1, 2022v2 Show 10 more changesShow less
    • Eligibility criteria expanded, about 14 words
    • Primary endpoints: 3 to 1
    • Enrollment target: 260 to 200
    • Primary completion date: Dec 31, 2026 to Oct 31, 2026
    • Study completion date: Jun 30, 2027 to Oct 30, 2027
    • Interventions: Left Atrial Appendage Closure (Procedure) to Combined Pulsed-field Ablation (PFA) (Procedure)
    • Secondary endpoints expanded, about 48 words
    • Study description expanded, about 31 words
    • Publications: 5 to 13
    • Study title expanded, about 10 words
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Rate of >=moderate peri-device leak (i.e. >=3mm) on follow-up TEE
Timeframe: 45-90 days

Secondary (10)

LAAO technical success rate
Rate of procedural related complications
Total ablation time
LAAO procedural time
Need of additional transseptal puncture for LAAO
Show 5 moreShow less
Number of device recapture (full or partial)
Number of device used
PFA acute technical success
AF ablation procedural success
Number of Participants with 1-year clinical events

Arms and interventions

Watchman Flx ProActive comparator

Watchman Flx Pro device to be used for LAAO

AmuletActive comparator

Amulet device to be used for LAAO

Devices: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO)

Sites

3 sites in 2 countries

Hong Kong 2, Macau 1